Database

Startups

Main Industry
Biotechnology
Founded Year
2013
Unified Business No.
54326052
Status
Active
Number of Employees
7
Total Paid-in Capital
969,934,100 (NT$)
Location of Company
Taiwan , Taipei City
Exit Status
Emerging Stock Exchange(2023)、OTC listing(2026)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.

Similar Companies

EVERFRONT BIOTECH INC.

1. EF-001 (Cerebraca® Wafer)
2. EF-009 Wafer
3. HK-001
4. EF-031
5. TSCA-001
6. EF-011

FORESEE PHARMACEUTICALS CO., LTD.

1. CAMCEVI 42 mg
2. CAMCEVI 21 mg
3. FP-025
4. FP-045
5. Aderamastat (FP-025) Phase 2 Study

Great Novel Therapeutics Biotech & Medicals Corporation

GNTbm focuses on the R&D of oral new drugs in cancer immunotherapy, including tumor microenvironment regulators (TMRs), epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors.

AltruBio Taiwan Inc.

AltruBio’s lead drug candidates are PSGL-1 agonist antibodies serving as immune checkpoint enhancers: ALTB-168, their first-generation molecule, has demonstrated safety and efficacy in Phase 1 and Phase 2 trials; and the next-generation ALTB-268, a tetrav
:::
回頁面最頂端